379 related articles for article (PubMed ID: 30589451)
1. Aberrant IL-35 levels in patients with primary Sjogren's syndrome.
Guo J; Gu M; Zhang W; Liu Y; Qian C; Deng A
Scand J Immunol; 2018 Nov; 88(5):e12718. PubMed ID: 30589451
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome.
Ciccia F; Accardo-Palumbo A; Alessandro R; Alessandri C; Priori R; Guggino G; Raimondo S; Carubbi F; Valesini G; Giacomelli R; Rizzo A; Triolo G
Clin Exp Immunol; 2015 Aug; 181(2):230-8. PubMed ID: 25902739
[TBL] [Abstract][Full Text] [Related]
3. Role of the IL-12/IL-35 balance in patients with Sjögren syndrome.
Fogel O; Rivière E; Seror R; Nocturne G; Boudaoud S; Ly B; Gottenberg JE; Le Guern V; Dubost JJ; Nititham J; Taylor KE; Chanson P; Dieudé P; Criswell LA; Jagla B; Thai A; Mingueneau M; Mariette X; Miceli-Richard C
J Allergy Clin Immunol; 2018 Jul; 142(1):258-268.e5. PubMed ID: 28916184
[TBL] [Abstract][Full Text] [Related]
4. Single-Cell RNA Sequencing Reveals the Expansion of Cytotoxic CD4
Hong X; Meng S; Tang D; Wang T; Ding L; Yu H; Li H; Liu D; Dai Y; Yang M
Front Immunol; 2020; 11():594658. PubMed ID: 33603736
[TBL] [Abstract][Full Text] [Related]
5. Decreased IL-35 levels in patients with immune thrombocytopenia.
Yang Y; Xuan M; Zhang X; Zhang D; Fu R; Zhou F; Ma L; Li H; Xue F; Zhang L; Yang R
Hum Immunol; 2014 Aug; 75(8):909-13. PubMed ID: 24994465
[TBL] [Abstract][Full Text] [Related]
6. CD4+CXCR5+ follicular helper T cells in salivary gland promote B cells maturation in patients with primary Sjogren's syndrome.
Jin L; Yu D; Li X; Yu N; Li X; Wang Y; Wang Y
Int J Clin Exp Pathol; 2014; 7(5):1988-96. PubMed ID: 24966908
[TBL] [Abstract][Full Text] [Related]
7. Decreased CD4+CD25+bright T cells in peripheral blood of patients with primary Sjogren's syndrome.
Liu MF; Lin LH; Weng CT; Weng MY
Lupus; 2008 Jan; 17(1):34-9. PubMed ID: 18089681
[TBL] [Abstract][Full Text] [Related]
8. IL-35 inhibits HBV antigen-specific IFN-γ-producing CTLs in vitro.
Li X; Tian L; Dong Y; Zhu Q; Wang Y; Han W; Liu X; Ni Q; Chen Y; Li L
Clin Sci (Lond); 2015 Sep; 129(5):395-404. PubMed ID: 25869609
[TBL] [Abstract][Full Text] [Related]
9. Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sjögren's syndrome.
Wang-Renault SF; Boudaoud S; Nocturne G; Roche E; Sigrist N; Daviaud C; Bugge Tinggaard A; Renault V; Deleuze JF; Mariette X; Tost J
Ann Rheum Dis; 2018 Jan; 77(1):133-140. PubMed ID: 28916716
[TBL] [Abstract][Full Text] [Related]
10. Methylation profile of the promoter region of IRF5 in primary Sjögren's syndrome.
Gestermann N; Koutero M; Belkhir R; Tost J; Mariette X; Miceli-Richard C
Eur Cytokine Netw; 2012; 23(4):166-72. PubMed ID: 23302156
[TBL] [Abstract][Full Text] [Related]
11. Elevated level of circulating CD4
Liu C; Guan Z; Zhao L; Song Y; Wang H
Mod Rheumatol; 2017 Jul; 27(4):630-637. PubMed ID: 27538522
[TBL] [Abstract][Full Text] [Related]
12. The Clinical Relevance of IL-17-Producing CD4+CD161+ Cell and Its Subpopulations in Primary Sjögren's Syndrome.
Li L; He J; Zhu L; Yang Y; Jin Y; Jia R; Liu X; Liu Y; Sun X; Li Z
J Immunol Res; 2015; 2015():307453. PubMed ID: 26436101
[TBL] [Abstract][Full Text] [Related]
13. Increased frequency of CCR7
Wu C; Yang P; Liu H; Xiao W; Zhao L
Cytokine; 2018 Oct; 110():9-17. PubMed ID: 29684636
[TBL] [Abstract][Full Text] [Related]
14. STAT-5 is activated constitutively in T cells, B cells and monocytes from patients with primary Sjögren's syndrome.
Pertovaara M; Silvennoinen O; Isomäki P
Clin Exp Immunol; 2015 Jul; 181(1):29-38. PubMed ID: 25736842
[TBL] [Abstract][Full Text] [Related]
15. Peripheral regulatory cells immunophenotyping in primary Sjögren's syndrome: a cross-sectional study.
Furuzawa-Carballeda J; Hernández-Molina G; Lima G; Rivera-Vicencio Y; Férez-Blando K; Llorente L
Arthritis Res Ther; 2013; 15(3):R68. PubMed ID: 23800367
[TBL] [Abstract][Full Text] [Related]
16. Overlap between differentially methylated DNA regions in blood B lymphocytes and genetic at-risk loci in primary Sjögren's syndrome.
Miceli-Richard C; Wang-Renault SF; Boudaoud S; Busato F; Lallemand C; Bethune K; Belkhir R; Nocturne G; Mariette X; Tost J
Ann Rheum Dis; 2016 May; 75(5):933-40. PubMed ID: 26183421
[TBL] [Abstract][Full Text] [Related]
17. Increased interleukin (IL)-7Rα expression in salivary glands of patients with primary Sjogren's syndrome is restricted to T cells and correlates with IL-7 expression, lymphocyte numbers and activity.
Bikker A; Kruize AA; Wenting M; Versnel MA; Bijlsma JW; Lafeber FP; van Roon JA
Ann Rheum Dis; 2012 Jun; 71(6):1027-33. PubMed ID: 22312161
[TBL] [Abstract][Full Text] [Related]
18. Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-γ secreting cells.
Liaskou E; Patel SR; Webb G; Bagkou Dimakou D; Akiror S; Krishna M; Mells G; Jones DE; Bowman SJ; Barone F; Fisher BA; Hirschfield GM
J Autoimmun; 2018 Nov; 94():143-155. PubMed ID: 30119881
[TBL] [Abstract][Full Text] [Related]
19. CD4 T lymphocyte autophagy is upregulated in the salivary glands of primary Sjögren's syndrome patients and correlates with focus score and disease activity.
Alessandri C; Ciccia F; Priori R; Astorri E; Guggino G; Alessandro R; Rizzo A; Conti F; Minniti A; Barbati C; Vomero M; Pendolino M; Finucci A; Ortona E; Colasanti T; Pierdominici M; Malorni W; Triolo G; Valesini G
Arthritis Res Ther; 2017 Jul; 19(1):178. PubMed ID: 28743286
[TBL] [Abstract][Full Text] [Related]
20. Blockade of Th17 response by IL-38 in primary Sjögren's syndrome.
Luo D; Chen Y; Zhou N; Li T; Wang H
Mol Immunol; 2020 Nov; 127():107-111. PubMed ID: 32950755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
